Jump to main content
Jump to site search

Issue 23, 2017
Previous Article Next Article

Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides

Author affiliations

Abstract

Cancer is currently one of the world's most serious public health problems. Significant efforts are being made to develop new strategies that can eradicate tumours selectively without detrimental effects to healthy cells. One promising approach is focused on the design of vaccines that contain partially glycosylated mucins in their formulation. Although some of these vaccines are in clinical trials, a lack of knowledge about the molecular basis that governs the antigen presentation, and the interactions between antigens and the elicited antibodies has limited their success thus far. This review focuses on the most significant milestones achieved to date in the conformational analysis of tumour-associated MUC1 derivatives both in solution and bound to antibodies. The effect that the carbohydrate scaffold has on the peptide backbone structure and the role of the sugar in molecular recognition by antibodies are emphasised. The outcomes summarised in this review may be a useful guide to develop new antigens for the design of cancer vaccines in the near future.

Graphical abstract: Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides

Back to tab navigation

Publication details

The article was received on 29 Nov 2016 and first published on 12 Oct 2017


Article type: Tutorial Review
DOI: 10.1039/C6CS00858E
Citation: Chem. Soc. Rev., 2017,46, 7154-7175
  •   Request permissions

    Principles of mucin structure: implications for the rational design of cancer vaccines derived from MUC1-glycopeptides

    N. Martínez-Sáez, J. M. Peregrina and F. Corzana, Chem. Soc. Rev., 2017, 46, 7154
    DOI: 10.1039/C6CS00858E

Search articles by author

Spotlight

Advertisements